Publications

Executive Brief The First Nations Health Authority (FNHA), formed in 2013 in the province of British Columbia, is the first province-wide health authority of its kind in Canada. Its objective is the full transferral of programs, services, and responsibilities that were under Health Canada’s First Nations Inuit Health Branch (FNIHB) − Pacific Region’s former jurisdiction. One of the many components of the FNIHB’s programs is the Non-Insured … Read More →

pCPA Panel On Tuesday, June 13, 2017, the Canadian Association for Healthcare Reimbursement (CAHR) held the Market Access 201 conference in Toronto. The theme for this conference was Parallel or Intersecting Paths, the Future of Public and Private Reimbursement in Canada which consisted of five fascinating panels focusing on key topics of interest to the Canadian pharmaceutical stakeholders. Over the past several weeks, MORSE has been releasing summaries for … Read More →

Quebec Panel On Tuesday, June 13, 2017, the Canadian Association for Healthcare Reimbursement (CAHR) held the Market Access 201 conference in Toronto. The theme for this conference was Parallel or Intersecting Paths, the Future of Public and Private Reimbursement in Canada which consisted of five fascinating panels focusing on key topics of interest to the Canadian pharmaceutical stakeholders. Over the coming weeks, MORSE will be releasing summaries for each … Read More →

Health Technology Assessment Panel On Tuesday, June 13, 2017, the Canadian Association for Healthcare Reimbursement (CAHR) held the Market Access 201 conference in Toronto. The theme for this conference was Parallel or Intersecting Paths, the Future of Public and Private Reimbursement in Canada which consisted of five fascinating panels focusing on key topics of interest to the Canadian pharmaceutical stakeholders. Over the coming weeks, MORSE will be releasing summaries … Read More →

Biosimilar Panel On Tuesday, June 13, 2017, the Canadian Association for Healthcare Reimbursement (CAHR) held the Market Access 201 conference in Toronto. The theme for this conference was “Parallel or Intersecting Paths, the Future of Public and Private Reimbursement in Canada” which consisted of five fascinating panels focusing on key topics of interest to the Canadian pharmaceutical stakeholders. Over the coming weeks, MORSE will be releasing summaries for each … Read More →

DKDA Consulting and MORSE Consulting have created an infographic which provides key tips to planning, preparing, and participating in market access advisory board meetings. These insights are drawn from an article produced earlier this month: Market Access Advisory Board Meetings: Bridging the Gap Between Market Access and Internal Stakeholders. Click the image for full-size version Embed this infographic on your website with attribution: <a href=”http://morseconsulting.ca/bridging-gap-market-access-internal-stakeholders-infographic/”><img title=”Bridging … Read More →

Dominika Dabrowski (DKDA Consulting), Arvind Mani (MORSE Consulting), and Sherry O’Quinn (MORSE Consulting) have collaborated on an article that describes best practices for organizing and executing effective market access Advisory Board Meetings. Market Access teams often bridge the Clinical and Commercial silos, and as such, Market Access Managers play a critical role in the development and implementation of effective strategies that need to satisfy competing department objectives. One of the … Read More →

Pink Sheet Pharma Intelligence published the attached article by Francesca Bruce on February 17, 2017. The article provides a helpful summary of the current pan-Canadian Pharmaceutical Alliance (pCPA) Biologics/Biosimilar Consultations. We thank Ms. Bruce for seeking our perspective on this topic and Pink Sheet for granting permission to post this article. A copy of the article can be downloaded here. Source article on Pink Sheet To receive … Read More →